Ocular Therapeutix, Inc. (OCUL) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 2.27B |
| Enterprise Value | 1.62B |
| P/E Ratio | -6.46 |
| PEG Ratio | 0.28 |
| Price/Sales Ratio | 39.68 |
| Price/Book Ratio | 3.63 |
| Enterprise/Revenue | 28.39 |
| Enterprise/EBITDA | -5.39 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -5.58 |
| Operating Margin | -5.75 |
| Return On Assets | -0.4 |
| Return On Equity | -0.65 |
| Revenue | 51.82M |
| Revenue/Share | 0.23 |
| Gross Profit | 45.25M |
| EBITDA | -249.78M |
| Net Income | -265.94M |
| Diluted EPS | -1.42 |
| Total Cash | 666.7M |
| Total Cash/Share | 2.98 |
| Total Debt | 79.46M |
| Total Debt/Equity | 0.14 |
| Current Ratio | 14.81 |
| Book Value Per Share | 2.6 |
| 52-Week Change | 12.66 |
| 52-Week High | 16.44 |
| 52-Week Low | 6.23 |
| Moving Average 50 Days | 9.02 |
| Moving Average 200 Days | 10.51 |
| Average Volume | 3.1M |
| Shares Outstanding | 218.96M |
| % Held by Institutions | 110.41 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |